Oral Glutamine in the Prevention of Oxaliplatin-induced Neurotoxicity

Clinical trial NCT01087658 · COMPLETED

Trial details

NCT number: NCT01087658
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Colorectal Neoplasms

Start date: 2010-02-01
Primary completion: 2013-03-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.